Live
- Building plans’ approval should be as per rules: Commissioner Mourya
- England-New Zealand Test series to be named after Graham Thorpe and Martin Crowe
- World class sports complex in Tirupati soon
- Aware of 10 deaths linked to compounded semaglutide intake: Novo Nordisk
- SRKR teams selected for national netball championship
- CV Raman Birth Anniversary 2024 Celebrating the Legacy of a Legendary Scientist
- Chhath Puja 2024: Sandhya Arghya Sunset Timings for Major Cities Including Delhi, Mumbai, Patna & More
- Cancer care centres in Assam offer affordable treatment: CM Sarma
- Key Innovations in Cancer Treatment
- OpenAI Acquires Chat.com to Strengthen AI Accessibility with ChatGPT
Dr Reddy's, RDIF commence clinical trials for Sputnik vaccine
Dr Reddy’s, RDIF commence clinical trials for Sputnik vaccine
Highlights
Dr Reddy's Laboratories Ltd and the Russian Direct Investment Fund (RDIF) on Tuesday announced commencement of adaptive phase 2/3 clinical trials for...
Dr Reddy's Laboratories Ltd and the Russian Direct Investment Fund (RDIF) on Tuesday announced commencement of adaptive phase 2/3 clinical trials for COVID-19 vaccine Sputnik V in India after receiving necessary clearance from the Central Drugs Laboratory, Kasauli in Himachal Pradesh.
Next Story
ADVERTISEMENT
